The role of catalytic iron in acute kidney injury - PubMed (original) (raw)
Editorial
. 2011 Oct;6(10):2329-31.
doi: 10.2215/CJN.08340811.
- PMID: 21979910
- DOI: 10.2215/CJN.08340811
Editorial
The role of catalytic iron in acute kidney injury
Sudhir V Shah et al. Clin J Am Soc Nephrol. 2011 Oct.
No abstract available
Comment on
- Urinary hepcidin-25 and risk of acute kidney injury following cardiopulmonary bypass.
Ho J, Reslerova M, Gali B, Gao A, Bestland J, Rush DN, Nickerson PW, Rigatto C. Ho J, et al. Clin J Am Soc Nephrol. 2011 Oct;6(10):2340-6. doi: 10.2215/CJN.01000211. Epub 2011 Sep 1. Clin J Am Soc Nephrol. 2011. PMID: 21885789 Free PMC article.
Similar articles
- Urinary hepcidin: an inverse biomarker of acute kidney injury after cardiopulmonary bypass?
Prowle JR, Westerman M, Bellomo R. Prowle JR, et al. Curr Opin Crit Care. 2010 Dec;16(6):540-4. doi: 10.1097/MCC.0b013e32833ecdcc. Curr Opin Crit Care. 2010. PMID: 20736824 - Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study.
Ho J, Lucy M, Krokhin O, Hayglass K, Pascoe E, Darroch G, Rush D, Nickerson P, Rigatto C, Reslerova M. Ho J, et al. Am J Kidney Dis. 2009 Apr;53(4):584-95. doi: 10.1053/j.ajkd.2008.10.037. Epub 2008 Dec 13. Am J Kidney Dis. 2009. PMID: 19070948 - Hepcidin levels in acute kidney injury following cardiopulmonary bypass grafting.
Laarakkers CM, Wetzels JF, Swinkels DW. Laarakkers CM, et al. Am J Kidney Dis. 2009 Nov;54(5):979; author reply 980. doi: 10.1053/j.ajkd.2009.06.045. Am J Kidney Dis. 2009. PMID: 19853199 No abstract available. - Cardiopulmonary bypass-associated acute kidney injury.
Kumar AB, Suneja M. Kumar AB, et al. Anesthesiology. 2011 Apr;114(4):964-70. doi: 10.1097/ALN.0b013e318210f86a. Anesthesiology. 2011. PMID: 21394005 Review. No abstract available. - [Acute renal failure in patients following open heart surgery with cardiopulmonary bypass].
Kołataj P, Imiela J. Kołataj P, et al. Pol Arch Med Wewn. 1991 Dec;86(6):382-90. Pol Arch Med Wewn. 1991. PMID: 1819788 Review. Polish. No abstract available.
Cited by
- Renal-specific loss of ferroportin disrupts iron homeostasis and attenuates recovery from acute kidney injury.
Soofi A, Li V, Beamish JA, Abdrabh S, Hamad M, Das NK, Shah YM, Dressler GR. Soofi A, et al. Am J Physiol Renal Physiol. 2024 Feb 1;326(2):F178-F188. doi: 10.1152/ajprenal.00184.2023. Epub 2023 Nov 23. Am J Physiol Renal Physiol. 2024. PMID: 37994409 - Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications.
Kontoghiorghes GJ. Kontoghiorghes GJ. Int J Mol Sci. 2023 Aug 18;24(16):12928. doi: 10.3390/ijms241612928. Int J Mol Sci. 2023. PMID: 37629109 Free PMC article. Review. - TRIM21 ubiquitylates GPX4 and promotes ferroptosis to aggravate ischemia/reperfusion-induced acute kidney injury.
Sun X, Huang N, Li P, Dong X, Yang J, Zhang X, Zong WX, Gao S, Xin H. Sun X, et al. Life Sci. 2023 May 15;321:121608. doi: 10.1016/j.lfs.2023.121608. Epub 2023 Mar 21. Life Sci. 2023. PMID: 36958437 Free PMC article. - Effect of Cisplatin on Renal Iron Homeostasis Components: Implication in Nephropathy.
Aggarwal A, Dinda AK, Mukhopadhyay CK. Aggarwal A, et al. ACS Omega. 2022 Aug 1;7(32):27804-27817. doi: 10.1021/acsomega.1c06716. eCollection 2022 Aug 16. ACS Omega. 2022. PMID: 35990481 Free PMC article. - Treatment of Iron Deficiency Anemia in CKD and End-Stage Kidney Disease.
Gutiérrez OM. Gutiérrez OM. Kidney Int Rep. 2021 Jun 5;6(9):2261-2269. doi: 10.1016/j.ekir.2021.05.020. eCollection 2021 Sep. Kidney Int Rep. 2021. PMID: 34514189 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources